BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16449592)

  • 1. Systems analysis of real-world obstacles to successful cervical cancer prevention in developing countries.
    Suba EJ; Murphy SK; Donnelly AD; Furia LM; Huynh ML; Raab SS
    Am J Public Health; 2006 Mar; 96(3):480-7. PubMed ID: 16449592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of Cervical Cancer in the Developing World.
    Sankaranarayanan R
    Int J Gynaecol Obstet; 2006 Nov; 95 Suppl 1():S205-S210. PubMed ID: 29644674
    [No Abstract]   [Full Text] [Related]  

  • 3. Researchers should no longer delay implementation of Pap screening in low and middle income countries pending research into novel screening approaches.
    Suba EJ
    Infect Agent Cancer; 2024 Apr; 19(1):18. PubMed ID: 38671517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WHO should adjust its global strategy for cervical cancer prevention.
    Suba EJ; Donnelly AD; Duong DV; Gonzalez Mena LE; Neethling GS; Thai NV
    BMJ Glob Health; 2023 Jun; 8(6):. PubMed ID: 37308263
    [No Abstract]   [Full Text] [Related]  

  • 5. Unethical US Government-Funded Cervical Screening Study in India: US Freedom of Information Act Disclosures.
    Suba EJ; Ortega RE; Mutch DG
    J Healthc Sci Humanit; 2018; 8(2):57-78. PubMed ID: 36818400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Pap Test Awareness Critical to Pap Test Uptake in Women Living in Rural Vietnam?
    Lee HY; Li Q; Luo Y; Wang K; Hendrix S; Lee J; Yoon S; Nguyen Vu QH
    Asian Pac J Cancer Prev; 2021 Mar; 22(3):903-908. PubMed ID: 33773556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Operational Research in Health-care Settings.
    Kunwar R; Srivastava VK
    Indian J Community Med; 2019; 44(4):295-298. PubMed ID: 31802787
    [No Abstract]   [Full Text] [Related]  

  • 8. Cervical cancer screening decentralized policy adaptation: an African rural-context-specific systematic literature review.
    Rahman R; Clark MD; Collins Z; Traore F; Dioukhane EM; Thiam H; Ndiaye Y; De Jesus EL; Danfakha N; Peters KE; Komarek T; Linn AM; Linn PE; Wallner KE; Charles M; Hasnain M; Peterson CE; Dykens JA
    Glob Health Action; 2019; 12(1):1587894. PubMed ID: 30938248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate of opportunistic pap smear screening and patterns of epithelial cell abnormalities in pap smears in ajman, United arab emirates.
    Al Eyd GJ; Shaik RB
    Sultan Qaboos Univ Med J; 2012 Nov; 12(4):473-8. PubMed ID: 23275844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural barriers to screening for and treatment of cervical cancer in Peru.
    Paz-Soldán VA; Bayer AM; Nussbaum L; Cabrera L
    Reprod Health Matters; 2012 Dec; 20(40):49-58. PubMed ID: 23245408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Public health systems analysis--the transfer of learning between developed and developing countries.
    Thunhurst C
    Health Care Manag Sci; 2012 Sep; 15(3):283-91. PubMed ID: 22350688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meeting global health challenges through operational research and management science.
    Royston G
    Bull World Health Organ; 2011 Sep; 89(9):683-8. PubMed ID: 21897489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of epithelial cell abnormality in Pap smear: A clinicopathological and demographic correlation.
    Banik U; Bhattacharjee P; Ahamad SU; Rahman Z
    Cytojournal; 2011; 8():8. PubMed ID: 21713015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between plasma glucose levels and malignant uterine cervical neoplasias.
    Nomelini RS; Neto AS; Capuci KA; Murta BM; Murta EF
    Clin Med Insights Oncol; 2011; 5():77-82. PubMed ID: 21603242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons learned from successful Papanicolaou cytology cervical cancer prevention in the Socialist Republic of Vietnam.
    Suba EJ; Raab SS
    Diagn Cytopathol; 2012 Apr; 40(4):355-66. PubMed ID: 21394935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Social values and scientific evidence: the case of the HPV vaccines.
    Intemann K; de Melo-Martín I
    Biol Philos; 2010 Jan; 25(2):203-213. PubMed ID: 20526463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of patient adherence and test performance on the cost-effectiveness of cervical cancer screening in developing countries: the case of Honduras.
    Perkins RB; Langrish SM; Stern LJ; Burgess JF; Simon CJ
    Womens Health Issues; 2010; 20(1):35-42. PubMed ID: 19944623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Test group biases and ethical concerns mar New England Journal of Medicine articles promoting HPV screening for cervical cancer in rural India.
    Austin RM; Zhao C
    Cytojournal; 2009 Jul; 6():12. PubMed ID: 19633722
    [No Abstract]   [Full Text] [Related]  

  • 19. Papanicolaou test in the detection of high-grade cervical lesions: a re-evaluation based on cytohistologic non-correlation rates in 356 concurrently obtained samples.
    Carns B; Fadare O
    Int J Clin Exp Pathol; 2008 Jan; 1(3):285-90. PubMed ID: 18784830
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.